LeMaitre Vascular (NASDAQ: LMAT) net income
LeMaitre Vascular reported a net profit of $57.7m for fiscal 2025, 31.1% more than in fiscal 2024 ($44.0m). Its net margin was 23.1%. Earnings per share were $2.55.
LeMaitre Vascular has grown its net income for 3 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2022, −23.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $57.7m | +31.1% | 23.1% | $2.55 |
| 2024 | $44.0m | +46.3% | 20.0% | $1.96 |
| 2023 | $30.1m | +45.9% | 15.6% | $1.36 |
| 2022 | $20.6m | −23.3% | 12.8% | $0.94 |
| 2021 | $26.9m | +26.8% | 17.4% | $1.27 |
| 2020 | $21.2m | +18.3% | 16.4% | $1.05 |
| 2019 | $17.9m | −21.8% | 15.3% | $0.91 |
| 2018 | $22.9m | +33.6% | 21.7% | $1.18 |
| 2017 | $17.2m | +62.2% | 17.0% | $0.91 |
| 2016 | $10.6m | — | 11.9% | $0.57 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
LeMaitre Vascular net income compared with its sector
By net income for its latest fiscal year, LeMaitre Vascular ranks 131st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of LeMaitre Vascular, 23.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 129th | Kiniksa Pharmaceuticals International | $59.0m | 8.7% |
| 130th | Progyny | $58.5m | 4.5% |
| 131st | LeMaitre Vascular | $57.7m | 23.1% |
| 132nd | Emergent Biosolutions | $52.6m | 7.1% |
| 133rd | Repligen | $48.9m | 6.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of LeMaitre Vascular
- How much did LeMaitre Vascular earn in fiscal 2025?
- LeMaitre Vascular reported a net profit of $57.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $44.0m.
- What are the earnings per share of LeMaitre Vascular?
- They were $2.55 in fiscal 2025, compared with $1.96 in fiscal 2024.
- What is the net margin of LeMaitre Vascular?
- In fiscal 2025 its net profit was 23.1% of its revenue.
- What was the most profitable year for LeMaitre Vascular?
- Of its last 10 fiscal years, fiscal 2025, with $57.7m.
- Where does LeMaitre Vascular rank in its sector by net income?
- It ranks 131st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for LeMaitre Vascular come from?
- From the annual report (Form 10-K) that LeMaitre Vascular files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that LeMaitre Vascular files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on LeMaitre Vascular: the LeMaitre Vascular page · annual accounts · revenue · dividends paid · insider transactions.
Dividend per share of LeMaitre Vascular by fiscal year, with the filing behind every figure: LeMaitre Vascular dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.